Characterization of hepatitis B virus genotypes and quantitative hepatitis B surface antigen titres in North American tertiary referral liver centres (Q40117484)

From Wikidata

Jump to navigation Jump to search

scientific article published on 14 June 2013

Language	Label	Description	Also known as
English	Characterization of hepatitis B virus genotypes and quantitative hepatitis B surface antigen titres in North American tertiary referral liver centres	scientific article published on 14 June 2013

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

17 September 2017

Characterization of hepatitis B virus genotypes and quantitative hepatitis B surface antigen titres in North American tertiary referral liver centres (English)

1 reference

Europe PubMed Central

PubMed publication ID

17 September 2017

Hepatitis B virus

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

4

1 reference

Europe PubMed Central

PubMed publication ID

17 September 2017

object named as

Carla Osiowy

9

0 references

author name string

Stephen E Congly

1

1 reference

Europe PubMed Central

PubMed publication ID

17 September 2017

Philip Wong

2

1 reference

Europe PubMed Central

PubMed publication ID

17 September 2017

Said A Al-Busafi

3

1 reference

Europe PubMed Central

PubMed publication ID

17 September 2017

Scott K Fung

5

1 reference

Europe PubMed Central

PubMed publication ID

17 September 2017

Peter Ghali

6

1 reference

Europe PubMed Central

PubMed publication ID

17 September 2017

Kevin Fonseca

7

1 reference

Europe PubMed Central

PubMed publication ID

17 September 2017

Robert P Myers

8

1 reference

Europe PubMed Central

PubMed publication ID

17 September 2017

Carla S Coffin

10

1 reference

Europe PubMed Central

PubMed publication ID

17 September 2017

publication date

14 June 2013

1 reference

Europe PubMed Central

PubMed publication ID

17 September 2017

Liver International

1 reference

Europe PubMed Central

PubMed publication ID

17 September 2017

33

1 reference

Europe PubMed Central

PubMed publication ID

17 September 2017

9

1 reference

Europe PubMed Central

PubMed publication ID

17 September 2017

1363-1369

1 reference

Europe PubMed Central

PubMed publication ID

17 September 2017

Typing hepatitis B virus by homology in nucleotide sequence: comparison of surface antigen subtypes

1 reference

https://api.crossref.org/works/10.1111%2FLIV.12222

21 January 2018

Comparison of the amino acid sequences of nine different serotypes of hepatitis B surface antigen and genomic classification of the corresponding hepatitis B virus strains

1 reference

https://api.crossref.org/works/10.1111%2FLIV.12222

21 January 2018

Relationships between serotypes and genotypes of hepatitis B virus: genetic classification of HBV by use of surface genes

1 reference

https://api.crossref.org/works/10.1111%2FLIV.12222

21 January 2018

The clinical implications of hepatitis B virus genotype: Recent advances.

1 reference

https://api.crossref.org/works/10.1111%2FLIV.12222

21 January 2018

Hepatitis B virus: significance of genotypes

1 reference

https://api.crossref.org/works/10.1111%2FLIV.12222

21 January 2018

Hepatitis B virus genotype B is associated with earlier HBeAg seroconversion compared with hepatitis B virus genotype C.

1 reference

https://api.crossref.org/works/10.1111%2FLIV.12222

21 January 2018

Hepatitis B virus genotype and DNA level and hepatocellular carcinoma: a prospective study in men.

1 reference

https://api.crossref.org/works/10.1111%2FLIV.12222

21 January 2018

Impact of the hepatitis B virus genotype and genotype mixtures on the course of liver disease in Vietnam

1 reference

https://api.crossref.org/works/10.1111%2FLIV.12222

21 January 2018

Factors that predict response of patients with hepatitis B e antigen-positive chronic hepatitis B to peginterferon-alfa

1 reference

https://api.crossref.org/works/10.1111%2FLIV.12222

21 January 2018

Influence of hepatitis B virus genotype on the long-term outcome of chronic hepatitis B in western patients

1 reference

https://api.crossref.org/works/10.1111%2FLIV.12222

21 January 2018

Prevalence of HBV precore/core promoter variants in the United States

1 reference

https://api.crossref.org/works/10.1111%2FLIV.12222

21 January 2018

Hepatitis B virus genotypes and virologic response in 694 patients in phase III studies of adefovir dipivoxil1.

1 reference

https://api.crossref.org/works/10.1111%2FLIV.12222

21 January 2018

Impact of the hepatitis B virus genotype on pre- and post-liver transplantation outcomes

1 reference

https://api.crossref.org/works/10.1111%2FLIV.12222

21 January 2018

Genotype D amongst injection drug users with acute hepatitis B virus infection in British Columbia

1 reference

https://api.crossref.org/works/10.1111%2FLIV.12222

21 January 2018

Hepatitis B virus genotypes in Alaska Native people with hepatocellular carcinoma: preponderance of genotype F.

1 reference

https://api.crossref.org/works/10.1111%2FLIV.12222

21 January 2018

Epidemiology of hepatitis B in Canada

1 reference

https://api.crossref.org/works/10.1111%2FLIV.12222

21 January 2018

Seroprevalence of chronic hepatitis B virus infection and prior immunity in immigrants and refugees: a systematic review and meta-analysis.

1 reference

https://api.crossref.org/works/10.1111%2FLIV.12222

21 January 2018

Hepatitis B virus genotypes, precore and core promoter variants among predominantly Asian patients with chronic HBV infection in a Canadian center

1 reference

https://api.crossref.org/works/10.1111%2FLIV.12222

21 January 2018

Distinct geographical and demographic distribution of hepatitis B virus genotypes in the Canadian Arctic as revealed through an extensive molecular epidemiological survey

1 reference

https://api.crossref.org/works/10.1111%2FLIV.12222

21 January 2018

Hepatitis B surface antigen (HBsAg) levels in the natural history of hepatitis B virus (HBV)-infection: a European perspective.

1 reference

https://api.crossref.org/works/10.1111%2FLIV.12222

21 January 2018

Correlation between the Elecsys HBsAg II assay and the Architect assay for the quantification of hepatitis B surface antigen (HBsAg) in the serum

1 reference

https://api.crossref.org/works/10.1111%2FLIV.12222

21 January 2018

A comparison of two assays for quantification of Hepatitis B surface Antigen in patients with chronic hepatitis B.

1 reference

https://api.crossref.org/works/10.1111%2FLIV.12222

21 January 2018

A large case-control study on the predictability of hepatitis B surface antigen levels three years before hepatitis B surface antigen seroclearance.

1 reference

https://api.crossref.org/works/10.1111%2FLIV.12222

21 January 2018

Management of chronic hepatitis B: Canadian Association for the Study of the Liver consensus guidelines

1 reference

https://api.crossref.org/works/10.1111%2FLIV.12222

21 January 2018

Aspartate aminotransferase to platelet ratio index (APRI) can predict liver fibrosis in chronic hepatitis B.

1 reference

https://api.crossref.org/works/10.1111%2FLIV.12222

21 January 2018

Evaluation of the INNO-LiPA HBV genotyping assay for determination of hepatitis B virus genotype

1 reference

https://api.crossref.org/works/10.1111%2FLIV.12222

21 January 2018

Multicenter evaluation of the Elecsys hepatitis B surface antigen quantitative assay.

1 reference

https://api.crossref.org/works/10.1111%2FLIV.12222

21 January 2018

Comparison between Elecsys HBsAg II and architect HBsAg QT assays for quantification of hepatitis B surface antigen among patients coinfected with HIV and hepatitis B virus.

1 reference

https://api.crossref.org/works/10.1111%2FLIV.12222

21 January 2018

Hepatitis B surface antigen levels during the natural history of chronic hepatitis B: a perspective on Asia

1 reference

https://api.crossref.org/works/10.1111%2FLIV.12222

21 January 2018

Hepatitis B virus genotypes and G1896A precore mutation in 486 Spanish patients with acute and chronic HBV infection.

1 reference

https://api.crossref.org/works/10.1111%2FLIV.12222

21 January 2018

Genotypic Distribution of Hepatitis B Virus (HBV) Among Acute Cases of HBV Infection, Selected United States Counties, 1999-2005

1 reference

https://api.crossref.org/works/10.1111%2FLIV.12222

21 January 2018

Kinetics of hepatitis B surface antigen decline during 3 years of telbivudine treatment in hepatitis B e antigen-positive patients

1 reference

https://api.crossref.org/works/10.1111%2FLIV.12222

21 January 2018

Hepatitis B virus surface antigen levels: a guide to sustained response to peginterferon alfa-2a in HBeAg-negative chronic hepatitis B.

1 reference

https://api.crossref.org/works/10.1111%2FLIV.12222

21 January 2018

Early on-treatment prediction of response to peginterferon alfa-2a for HBeAg-negative chronic hepatitis B using HBsAg and HBV DNA levels

1 reference

https://api.crossref.org/works/10.1111%2FLIV.12222

21 January 2018

Quantification of hepatitis B surface antigen and E antigen: correlation between Elecsys and architect assays.

1 reference

https://api.crossref.org/works/10.1111%2FLIV.12222

21 January 2018

Clinical importance of serum hepatitis B surface antigen levels in chronic hepatitis B.

1 reference

https://api.crossref.org/works/10.1111%2FLIV.12222

21 January 2018

Hepatitis B surface antigen serum level is associated with fibrosis severity in treatment-naïve, e antigen-positive patients

1 reference

https://api.crossref.org/works/10.1111%2FLIV.12222

21 January 2018

Hepatitis B genotypes correlate with clinical outcomes in patients with chronic hepatitis B

1 reference

https://api.crossref.org/works/10.1111%2FLIV.12222

21 January 2018

Influence of genotype on hepatitis B surface antigen kinetics in hepatitis B e antigen-negative patients treated with pegylated interferon-α2a

1 reference

https://api.crossref.org/works/10.1111%2FLIV.12222

21 January 2018

Serum HBsAg Decline During Long-term Potent Nucleos(t)ide Analogue Therapy for Chronic Hepatitis B and Prediction of HBsAg Loss

1 reference

https://api.crossref.org/works/10.1111%2FLIV.12222

21 January 2018

Kinetics of hepatitis B surface antigen differ between treatment with peginterferon and entecavir

1 reference

https://api.crossref.org/works/10.1111%2FLIV.12222

21 January 2018

Identifiers

10.1111/LIV.12222

1 reference

Europe PubMed Central

PubMed publication ID

17 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

17 September 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q40117484&oldid=1885759205"